Chargement en cours...

A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher

BACKGROUND: Studies of octreotide in hepatocellular carcinoma have yielded conflicting results. Since past studies have excluded patients with highly advanced disease and given the fact that octreotide offers several potential physiologic benefits in patients with advanced cirrhosis, such as improvi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shah, Usman, O’Neil, Bert, Allen, Jill, Goldberg, Richard M., Bernard, Steven, Moore, Dominic, Venook, Alan P., Morse, Michael M.
Format: Artigo
Langue:Inglês
Publié: International Society of Gastrointestinal Oncology 2009
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2684718/
https://ncbi.nlm.nih.gov/pubmed/19461906
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!